Recruiting studies: Renal Replacement Therapy For Acute Kidney Injury In Icu

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury
Phase N/A · 1 location(s) · Dr. Gordon Boyd · NCT04722939 IHD Versus CRRT for Severe Acute Kidney Injury in Critically Ill Patients
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06032884 Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury
Phase 1/Phase 2 · 2 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT07236463 Timing of Renal Replacement Therapy Initiation in Tumor Lysis Syndrome
Phase N/A · 10 location(s) · University Hospital, Bordeaux · NCT06889974 Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients
Phase N/A · 10 location(s) · Hospital Las Higueras · NCT07643597 FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07718464 Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
Phase N/A · 15 location(s) · University of Alabama at Birmingham · NCT07262320 The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic
Phase N/A · 1 location(s) · Gulhane Training and Research Hospital · NCT06995222

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.